ScholarIQanswers from OpenAlex

Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy

PaperCitations, authors & open-access status

Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy have?

ScholarIQcitation count

Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy has 314 citations in the OpenAlex counts ScholarIQ stores.

When was Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy published?

ScholarIQyear

Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy has 2010 year in the ScholarIQ index.

What is the open-access status of Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy?

ScholarIQoa status

Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy has hybrid oa status in the ScholarIQ index.

What is the DOI of Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy?

ScholarIQdoi

The DOI for Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy is on the source record.

What is the PMID of Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy?

ScholarIQpmid

The PMID for Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy is on the source record.

What is the OpenAlex record for Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy?

ScholarIQopenalex

The OpenAlex for Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial